What is the role of vinblastine in the aMVAC regimen?
Label:chem
Topic
Vinblastine is included in the aMVAC regimen for treating muscle-invasive urothelial cancer.
Answer
Vinblastine is administered at a dose of 3 mg/m² on day one of the biweekly cycles in the aMVAC regimen. It contributes to the overall efficacy of the chemotherapy by targeting rapidly dividing cancer cells and is an integral part of the combination therapy.
Return to Home
Chemical List
Knowledge you may be interested in